TherapeuticsMD
TXMD
123 hedge funds and large institutions have $1.33B invested in TherapeuticsMD in 2015 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 34 reducing their positions, and 15 closing their positions.
217% more call options, than puts
Call options by funds: $20.5M | Put options by funds: $6.48M
86% more capital invested
Capital invested by funds: $716M → $1.33B (+$612M)
60% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 15
32% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 34
8% more funds holding
Funds holding: 114 → 123 (+9)
0.06% more ownership
Funds ownership: 1.38% → 1.44% (+0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.6M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$22.2M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$9.94M |
| 4 |
D.E. Shaw & Co
New York
|
+$5.04M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$4.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$14.5M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$8.9M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$4.55M |
| 4 |
JP Morgan Chase
New York
|
-$4.22M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3M |
TXMD Hedge Fund Activity: Q4 2015 in Review
123 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q4 2015, worth a combined $1.33B — up 86% from $716M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new TXMD positions and 15 closed out — a net gain of 9 holders — while 45 added to existing stakes and 34 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $29.6M. The largest seller was State Street, cutting an estimated $14.5M.
- 123 institutional investors held TherapeuticsMD (TXMD) as of Q4 2015, up from 114 in Q3 2015.
- Funds reported $1.33B of TherapeuticsMD stock for Q4 2015, up 86% quarter-over-quarter.
- 24 funds opened new TherapeuticsMD positions in Q4 2015 and 15 closed out, a net change of +9 holders.
- The largest TherapeuticsMD buyer in Q4 2015 was Fidelity Investments, an estimated $29.6M added.
- The largest TherapeuticsMD seller in Q4 2015 was State Street, an estimated $14.5M sold.
Based on aggregated 13F filings for Q4 2015.